Hainan Haiyao Co (000566) Fair Value & Analysis

Healthcare · CN · Market cap 5.0B CNY

Analysis

Hainan Haiyao Co (000566) currently trades at ¥3.71, while our model-based Fair Value estimate is ¥1.90 — implying the stock looks roughly 48.8% overvalued today. We read business quality at 94/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Hainan Haiyao Co., Ltd. manufactures and sells pharmaceutical products and medical devices in China and internationally. The company offers big health, digestive, anti-infective, respiratory, anti-tumor, vitamins, and chronic disease category products. It also provides active pharmaceutical ingredients and intermediates; traditional Chinese medicine decoction pieces; medical devices, including disposable medical mask, implant, and source processor; and medical services. In addition, the company offers chemical drugs, modern traditional Chinese medicine, biopharmaceuticals, and cell immunotherapy. Hainan Haiyao Co., Ltd. was founded in 1965 and is headquartered in Haikou, China.

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.